Outset Medical Inc (OM)
3.89
-0.25
(-6.04%)
USD |
NASDAQ |
Jun 28, 16:00
3.87
-0.02
(-0.51%)
After-Hours: 20:00
Outset Medical SG&A Expense (TTM): 137.84M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 137.84M |
December 31, 2023 | 141.46M |
September 30, 2023 | 142.58M |
June 30, 2023 | 138.32M |
March 31, 2023 | 136.03M |
December 31, 2022 | 130.00M |
September 30, 2022 | 129.05M |
June 30, 2022 | 120.13M |
Date | Value |
---|---|
March 31, 2022 | 109.08M |
December 31, 2021 | 101.39M |
September 30, 2021 | 92.92M |
June 30, 2021 | 96.00M |
March 31, 2021 | 87.17M |
December 31, 2020 | 75.58M |
September 30, 2020 | 60.49M |
June 30, 2020 | 41.51M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
41.51M
Minimum
Jun 2020
142.58M
Maximum
Sep 2023
108.72M
Average
114.60M
Median
SG&A Expense (TTM) Benchmarks
AngioDynamics Inc | 145.48M |
Baxter International Inc | 3.896B |
Allurion Technologies Inc | 88.24M |
Perspective Therapeutics Inc | 19.11M |
Xtant Medical Holdings Inc | 72.60M |